𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Minimal residual disease as the target for immunotherapy of cancer

✍ Scribed by G.J.V. Nossal

Book ID
118556318
Publisher
The Lancet
Year
1994
Tongue
English
Weight
552 KB
Volume
343
Category
Article
ISSN
0140-6736

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Tumor–antigen heterogeneity of dissemina
Tumor–antigen heterogeneity of disseminated breast cancer cells: Implications for immunotherapy of minimal residual disease
✍ Stephan Braun; Florian Hepp; Harald L. Sommer; Klaus Pantel πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 112 KB πŸ‘ 1 views

Single micrometastatic tumor cells encased in mesenchymal tissues, such as bone marrow (BM), are regarded as suitable targets for adjuvant immunotherapy since they are easily accessible for both immunoglobulins and immune effector cells. However, the antigen profile of such cells, to which antibody